CNTB Stock Price | Connect Biopharma Holdings Ltd P/E, Revenue, EPS, & Forecasts

Connect Biopharma Holdings Ltd • CNTB

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Connect Biopharma Holdings Ltd

Ticker

CNTB

Trading on

NASDAQ

ISIN

US2075231017

Industry

Biotechnology

Sector

Healthcare

CEO

Dr. Barry D. Quart Pharm.D.

Headquarters

3580 CARMEL MOUNTAIN ROAD, San Diego, CA, United States, 92130

Employees

Website

connectbiopharm.com

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States. The company's lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is in Phase 3 studies for the treatment of inflammatory diseases such as atopic dermatitis and asthma. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California.

Metrics

BasicAdvanced

Market cap

$139M

P/E ratio

EPS

-$0.89

Dividend Yield

0.00%

Beta

-0.18

Forward P/E ratio

0.77

EBIDTA

$-54.7M

Ex dividend date

Price & volume

Market cap

$139M

Average daily volume

0.1M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

0.77

PEG ratio

Trailing P/E

Price to sales

181.94

Price to book

2.48

Earnings

EPS

-$0.89

EPS estimate (current quarter)

-$0.24

EPS estimate (next quarter)

-$0.27

EBITDA

$-54.7M

Revenues (TTM)

$0.8M

Revenues per share (TTM)

$0.01

Technicals

Beta

-0.18

52-week High

$3.28

52-week Low

$0.51

50-day moving average

$2.51

200-day moving average

$1.92

Short ratio

3.4

Short %

0.84%

Management effectiveness

ROE (TTM)

-66.80%

ROA (TTM)

-38.67%

Profit margin

0.00%

Gross profit margin

$0.8M

Operating margin

-110,481.25%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

-98.70%

Share stats

Outstanding Shares

55.9M

Float

12.8M

Insiders %

38.47%

Institutions %

51.38%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 2 analysts.

Average price target

$7.90

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.42

Q4 • 24Beat

-$0.19

-$0.26

26.92%

Q1 • 25Beat

-$0.23

-$0.22

-4.55%

Q2 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-12.9M

-26,872.92%

Q2 • 25

$0M

$-17.2M

-107,500.00%

Q3 • 25

-66.67%

33.34%

300.03%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$82.7M

$11.4M

13.76%

Q2 • 25

$67.4M

$12M

17.80%

Q3 • 25

-18.57%

5.33%

29.36%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-12.6M

$5.1M

$0.2M

$-12.9M

Q2 • 25

$-17.4M

$14.4M

$0.2M

$-17.4M

Q3 • 25

38.24%

180.37%

33.54%

35.26%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Connect Biopharma Holdings Ltd share?

Connect Biopharma Holdings Ltd shares are currently traded for undefined per share.

How many shares does Connect Biopharma Holdings Ltd have?

Connect Biopharma Holdings Ltd currently has 55.9M shares.

Does Connect Biopharma Holdings Ltd pay dividends?

No, Connect Biopharma Holdings Ltd doesn't pay dividends.

What is Connect Biopharma Holdings Ltd 52 week high?

Connect Biopharma Holdings Ltd 52 week high is $3.28.

What is Connect Biopharma Holdings Ltd 52 week low?

Connect Biopharma Holdings Ltd 52 week low is $0.51.

What is the 200-day moving average of Connect Biopharma Holdings Ltd?

Connect Biopharma Holdings Ltd 200-day moving average is $1.92.

Who is Connect Biopharma Holdings Ltd CEO?

The CEO of Connect Biopharma Holdings Ltd is Dr. Barry D. Quart Pharm.D..

How many employees Connect Biopharma Holdings Ltd has?

Connect Biopharma Holdings Ltd has 62 employees.

What is the market cap of Connect Biopharma Holdings Ltd?

The market cap of Connect Biopharma Holdings Ltd is $139M.

What is the P/E of Connect Biopharma Holdings Ltd?

The current P/E of Connect Biopharma Holdings Ltd is null.

What is the EPS of Connect Biopharma Holdings Ltd?

The EPS of Connect Biopharma Holdings Ltd is -$0.89.

What is the PEG Ratio of Connect Biopharma Holdings Ltd?

The PEG Ratio of Connect Biopharma Holdings Ltd is null.

What do analysts say about Connect Biopharma Holdings Ltd?

According to the analysts Connect Biopharma Holdings Ltd is considered a buy.